STOCK TITAN

[Form 4] IDEX Corporation Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Helmkamp Katrina L, identified as a director of IDEX Corporation (IEX), purchased 2,500 shares of common stock on 08/07/2025 at a weighted average price of $159.6104 per share, in multiple trades priced between $159.51 and $159.65. After the reported acquisition, the reporting person beneficially owns 13,200 shares directly.

The Form 4 shows no derivative transactions in Table II. A footnote states the transaction was executed in multiple trades and that the reporting person will provide detailed per-trade quantities and prices upon request.

Helmkamp Katrina L, identificata come direttrice di IDEX Corporation (IEX), ha acquistato 2.500 azioni ordinarie il 08/07/2025 a un prezzo medio ponderato di $159.6104 per azione, in più operazioni con prezzi compresi tra $159.51 e $159.65. Dopo l'acquisizione comunicata, la persona che ha presentato la dichiarazione possiede direttamente 13.200 azioni.

Il Modulo 4 non riporta operazioni su derivati nella Tabella II. Una nota a piè di pagina indica che la transazione è stata eseguita in più operazioni e che la persona che ha presentato la dichiarazione fornirà, su richiesta, i dettagli delle quantità e dei prezzi per ogni singola operazione.

Helmkamp Katrina L, identificada como directora de IDEX Corporation (IEX), compró 2.500 acciones ordinarias el 08/07/2025 a un precio medio ponderado de $159.6104 por acción, en varias operaciones con precios entre $159.51 y $159.65. Tras la adquisición declarada, la persona declarante posee directamente 13.200 acciones.

El Formulario 4 no muestra transacciones de derivados en la Tabla II. Una nota indica que la operación se ejecutó en varias transacciones y que la persona declarante facilitará, a petición, las cantidades y precios por cada operación.

Helmkamp Katrina L는 IDEX Corporation (IEX)의 이사로 확인되었으며, 08/07/2025에 보통주 2,500주를 주당 가중평균 $159.6104에 복수의 거래로 매수했으며 거래 가격은 $159.51에서 $159.65 사이였습니다. 보고된 취득 이후 해당 보고인은 직접 13,200주를 보유하고 있습니다.

Form 4의 표 II에는 파생상품 거래가 없습니다. 각주에는 거래가 복수의 거래로 실행되었으며, 요청 시 거래별 수량 및 가격을 상세히 제공하겠다고 명시되어 있습니다.

Helmkamp Katrina L, identifiée comme directrice d'IDEX Corporation (IEX), a acheté 2 500 actions ordinaires le 08/07/2025 à un prix moyen pondéré de $159.6104 par action, lors de plusieurs opérations à des prix compris entre $159.51 et $159.65. Après l'acquisition déclarée, la personne déclarante détient directement 13 200 actions.

Le formulaire 4 n'indique aucune opération sur produits dérivés dans le tableau II. Une note précise que la transaction a été effectuée en plusieurs exécutions et que la personne déclarante fournira, sur demande, les quantités et prix détaillés par exécution.

Helmkamp Katrina L, ausgewiesen als Direktorin von IDEX Corporation (IEX), kaufte am 08/07/2025 2.500 Stammaktien zum gewichteten Durchschnittspreis von $159.6104 je Aktie in mehreren Transaktionen zu Preisen zwischen $159.51 und $159.65. Nach der gemeldeten Erwerbung hält die meldende Person direkt 13.200 Aktien.

Im Formular 4 sind in Tabelle II keine Derivattransaktionen aufgeführt. Eine Fußnote weist darauf hin, dass die Transaktion in mehreren Ausführungen erfolgte und die meldende Person auf Anfrage detaillierte Stückzahlen und Preise pro Ausführung zur Verfügung stellt.

Positive
  • Director purchase recorded: Helmkamp acquired 2,500 IEX shares.
  • Clear pricing detail: weighted average price $159.6104; trades ranged $159.51–$159.65.
  • Increased direct ownership: beneficial ownership rose to 13,200 shares.
  • No derivatives reported: Table II contains no derivative transactions.
Negative
  • None.

Insights

Director purchased 2,500 IEX shares at a weighted $159.61; routine disclosure with limited market impact.

The purchase increases the director's direct stake to 13,200 shares and was executed in multiple open-market trades at prices from $159.51 to $159.65, producing a weighted average of $159.6104. While insider buys can be a positive signal, the size of this acquisition appears modest relative to a public company and the filing provides no additional information on scale versus total outstanding shares or intent. No derivatives were reported, and the filing includes a standard footnote offering to disclose per-trade details on request.

Form 4 reflects standard Section 16 disclosure for a director open-market purchase, with required explanatory footnote present.

The reporting person is identified as a director and the Form 4 records a purchase transaction with a clear weighted average price and price range. Table II lists no derivative activity. The filing includes the customary undertaking to provide granular trade-level details to the SEC or issuer on request, indicating compliance with disclosure obligations. There are no governance issues or unusual items disclosed in this form.

Helmkamp Katrina L, identificata come direttrice di IDEX Corporation (IEX), ha acquistato 2.500 azioni ordinarie il 08/07/2025 a un prezzo medio ponderato di $159.6104 per azione, in più operazioni con prezzi compresi tra $159.51 e $159.65. Dopo l'acquisizione comunicata, la persona che ha presentato la dichiarazione possiede direttamente 13.200 azioni.

Il Modulo 4 non riporta operazioni su derivati nella Tabella II. Una nota a piè di pagina indica che la transazione è stata eseguita in più operazioni e che la persona che ha presentato la dichiarazione fornirà, su richiesta, i dettagli delle quantità e dei prezzi per ogni singola operazione.

Helmkamp Katrina L, identificada como directora de IDEX Corporation (IEX), compró 2.500 acciones ordinarias el 08/07/2025 a un precio medio ponderado de $159.6104 por acción, en varias operaciones con precios entre $159.51 y $159.65. Tras la adquisición declarada, la persona declarante posee directamente 13.200 acciones.

El Formulario 4 no muestra transacciones de derivados en la Tabla II. Una nota indica que la operación se ejecutó en varias transacciones y que la persona declarante facilitará, a petición, las cantidades y precios por cada operación.

Helmkamp Katrina L는 IDEX Corporation (IEX)의 이사로 확인되었으며, 08/07/2025에 보통주 2,500주를 주당 가중평균 $159.6104에 복수의 거래로 매수했으며 거래 가격은 $159.51에서 $159.65 사이였습니다. 보고된 취득 이후 해당 보고인은 직접 13,200주를 보유하고 있습니다.

Form 4의 표 II에는 파생상품 거래가 없습니다. 각주에는 거래가 복수의 거래로 실행되었으며, 요청 시 거래별 수량 및 가격을 상세히 제공하겠다고 명시되어 있습니다.

Helmkamp Katrina L, identifiée comme directrice d'IDEX Corporation (IEX), a acheté 2 500 actions ordinaires le 08/07/2025 à un prix moyen pondéré de $159.6104 par action, lors de plusieurs opérations à des prix compris entre $159.51 et $159.65. Après l'acquisition déclarée, la personne déclarante détient directement 13 200 actions.

Le formulaire 4 n'indique aucune opération sur produits dérivés dans le tableau II. Une note précise que la transaction a été effectuée en plusieurs exécutions et que la personne déclarante fournira, sur demande, les quantités et prix détaillés par exécution.

Helmkamp Katrina L, ausgewiesen als Direktorin von IDEX Corporation (IEX), kaufte am 08/07/2025 2.500 Stammaktien zum gewichteten Durchschnittspreis von $159.6104 je Aktie in mehreren Transaktionen zu Preisen zwischen $159.51 und $159.65. Nach der gemeldeten Erwerbung hält die meldende Person direkt 13.200 Aktien.

Im Formular 4 sind in Tabelle II keine Derivattransaktionen aufgeführt. Eine Fußnote weist darauf hin, dass die Transaktion in mehreren Ausführungen erfolgte und die meldende Person auf Anfrage detaillierte Stückzahlen und Preise pro Ausführung zur Verfügung stellt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Helmkamp Katrina L

(Last) (First) (Middle)
3100 SANDERS ROAD
SUITE 301

(Street)
NORTHBROOK IL 60062

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IDEX CORP /DE/ [ IEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
COMMON STOCK 08/07/2025 P 2,500 A $159.6104(1) 13,200 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction was executed in multiple trades at prices ranging from $159.51 to 159.65, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in footnote 1 of this Form 4.
/s/ Sam Rayburn, by Power of Attorney 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the Form 4 report for IDEX (IEX)?

The Form 4 reports a purchase of 2,500 common shares by Helmkamp on 08/07/2025, with a weighted average price of $159.6104.

Who is the reporting person and what is their relationship to IEX?

The reporting person is Helmkamp Katrina L, who is checked as a Director of IDEX Corporation.

How many IEX shares does the reporting person own after the transaction?

After the reported acquisition the reporting person beneficially owns 13,200 shares directly.

What price range and average does the filing show for the trades?

Trades were executed at prices ranging from $159.51 to $159.65; the weighted average purchase price reported is $159.6104.

Are any derivative securities reported for IEX in this Form 4?

No. Table II shows no derivative securities acquired, disposed of, or beneficially owned.

Is there an explanatory note about the transaction details?

Yes. Footnote 1 states the transaction was executed in multiple trades within the stated price range and the reporting person will provide full per-trade details upon request.
IDEX

NYSE:IEX

IEX Rankings

IEX Latest News

IEX Latest SEC Filings

IEX Stock Data

12.02B
75.13M
0.21%
102.45%
3.44%
Specialty Industrial Machinery
Pumps & Pumping Equipment
Link
United States
NORTHBROOK